Evaluation of efficacy and anti-inflammatory action of PlacentrexTM in women with inflammatory Pap smears.
Phase 1
Completed
- Conditions
- Health Condition 1: null- To evaluate the efficacy and anti inflammatory action of Placentrex in women with inflammatory Pap smears.
- Registration Number
- CTRI/2010/091/000197
- Lead Sponsor
- ALBERT DAVID LTD KOLKATA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 150
Inclusion Criteria
PAP SMEAR SHOWING INFLAMMATION
ABILITY TO GIVE INFORMED CONSENT
SEXUALLY ACTIVE
NO DEBILITATING DISEASE
Exclusion Criteria
OBVIOUS GROWTH
PREVIOUS PROCEDURES, EG. EXCISION BIOPSY,CRYOTHERAPY AND CONISATION AND HYSTERECTOMY
ACUTE CERVICITIS AND VAGINITIS
PREGNANCY
SEVERE DEBILITATING DISEASE
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method repeat normal pap testTimepoint: Resolution of inflammatory Pap smear
- Secondary Outcome Measures
Name Time Method Resolution of inflammatory Pap smearTimepoint: